These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21083064)

  • 1. 'False-positive' and 'false-negative' test results in clinical urine drug testing.
    Reisfield GM; Goldberger BA; Bertholf RL
    Bioanalysis; 2009 Aug; 1(5):937-52. PubMed ID: 21083064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational use and interpretation of urine drug testing in chronic opioid therapy.
    Reisfield GM; Salazar E; Bertholf RL
    Ann Clin Lab Sci; 2007; 37(4):301-14. PubMed ID: 18000286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of interferences for gas chromatography/mass spectrometry analysis of urine for drugs of abuse.
    Wu AH
    Ann Clin Lab Sci; 1995; 25(4):319-29. PubMed ID: 7668815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferences with urine drug screens.
    Herring C; Muzyk AJ; Johnston C
    J Pharm Pract; 2011 Feb; 24(1):102-8. PubMed ID: 21507878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs of abuse testing in a psychiatric outpatient service.
    Shearer DS; Baciewicz GJ; Kwong TC
    Clin Lab Med; 1998 Dec; 18(4):713-26. PubMed ID: 9891610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.
    Bagøien G; Morken G; Zahlsen K; Aamo T; Spigset O
    J Clin Psychopharmacol; 2009 Jun; 29(3):248-54. PubMed ID: 19440078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine drug test interpretation: what do physicians know?
    Reisfield GM; Bertholf R; Barkin RL; Webb F; Wilson G
    J Opioid Manag; 2007; 3(2):80-6. PubMed ID: 17520987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine drug testing in pain medicine.
    Heit HA; Gourlay DL
    J Pain Symptom Manage; 2004 Mar; 27(3):260-7. PubMed ID: 15010104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family physicians' proficiency in urine drug test interpretation.
    Reisfield GM; Webb FJ; Bertholf RL; Sloan PA; Wilson GR
    J Opioid Manag; 2007; 3(6):333-7. PubMed ID: 18290585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine drug testing: current recommendations and best practices.
    Owen GT; Burton AW; Schade CM; Passik S
    Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illicit drug use in the pain patient population decreases with continued drug testing.
    Pesce A; West C; Rosenthal M; Mikel C; West R; Crews B; Almazan P; Latyshev S; Horn PS
    Pain Physician; 2011; 14(2):189-93. PubMed ID: 21412373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay in healthcare testing applications.
    DePriest AZ; Black DL; Robert TA
    J Opioid Manag; 2015; 11(1):13-25. PubMed ID: 25750161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.